Cargando…
Development of a qualitative assay for screening of Bordetella pertussis isolates for pertussis toxin production
Bordetella pertussis infection has been increasing in the US, with reported cases reaching over 50,000 in 2012, a number last observed in the 1950s. Concurrently, B. pertussis lacking the pertactin protein, one of the immunogens included in the acellular vaccine formulations, has rapidly emerged sin...
Autores principales: | Gates, Irina, DuVall, Marina, Ju, Hong, Tondella, M. Lucia, Pawloski, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386250/ https://www.ncbi.nlm.nih.gov/pubmed/28394915 http://dx.doi.org/10.1371/journal.pone.0175326 |
Ejemplares similares
-
Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin
por: Williams, Margaret M., et al.
Publicado: (2016) -
Genomic Survey of Bordetella pertussis Diversity, United States, 2000–2013
por: Weigand, Michael R., et al.
Publicado: (2019) -
Secretion of Pertussis Toxin from Bordetella pertussis
por: Burns, Drusilla L.
Publicado: (2021) -
Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT)
por: Lee, Adria D., et al.
Publicado: (2018) -
Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence
por: Mooi, Frits R., et al.
Publicado: (2009)